3//SEC Filing
Flagship Pioneering Fund VII, L.P. 3
Accession 0000899243-23-006240
CIK 0001850838other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:20 PM ET
Size
7.0 KB
Accession
0000899243-23-006240
Insider Transaction Report
Form 3
Holdings
- 1,329,324(indirect: By Flagship Pioneering Fund VII, L.P.)
Common Stock
Footnotes (2)
- [F1]On February 27, 2023, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") purchased 1,329,324 shares of the Issuer's Common Stock in a registered direct offering at a price of $5.78 per share pursuant to a Securities Purchase Agreement dated February 22, 2023.
- [F2]Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the Chief Executive Officer, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Fund VII disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001805916
Filing Metadata
- Form type
- 3
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:20 PM ET
- Size
- 7.0 KB